Loading...

Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer

Systematic analysis of the epidermal growth factor receptor (EGFR) pathway revealed that biomarkers could be used to predict the response to and outcome of anti-EGFR therapies in patients affected by metastatic colorectal cancer. We have conducted a review on the most recent findings and advances on...

Full description

Saved in:
Bibliographic Details
Main Authors: De Stefano, Alfonso, Carlomagno, Chiara
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123362/
https://ncbi.nlm.nih.gov/pubmed/25110411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i29.9732
Tags: Add Tag
No Tags, Be the first to tag this record!